Ultragenyx Pharmaceutical Market Sentiment

SPY776.30 QQQ754.60−0.67%BTC/USD83,551.11−2.33%DIA511.08 GLD377.96 TLT76.62−0.86%

Ultragenyx Pharmaceutical Inc

RARENASDAQ

Trade with Public

$14.46

-0.04-0.28%

Last update: Oct 7, 8:04 AM

$14.27

-0.23-1.61%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Ultragenyx Pharmaceutical Market Sentiment - Benzinga

Ultragenyx Pharmaceutical Market Sentiment

Market sentiment signals for Ultragenyx Pharmaceutical (RARE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 17.4% short float

Options Flow— N/A

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

27 analysts

Options Flow (P/C)

—

Avg Consensus PT

$48

+236.5%

Highest Price Target

$140

+881.3%

Piper Sandler

Lowest Price Target

$16

+12.2%

Baird

Short Interest

17.4%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 21, 2026	Evercore ISI Group	Liisa Bayko—	+26.2%	$16 → $18	Maintained	In-Line
Sep 21, 2026	Barclays	Eliana Merle—	+145.3%	$32 → $35	Maintained	Overweight
Sep 18, 2026	Morgan Stanley	Maxwell Skor—	+40.2%	$18 → $20	Maintained	Equal-Weight
Sep 18, 2026	Citigroup	Yigal Nochomovitz—	+124.3%	$31 → $32	Maintained	Buy
Sep 18, 2026	Canaccord Genuity	Whitney Ijem—	+173.4%	$37 → $39	Maintained	Buy
Sep 18, 2026	Cantor Fitzgerald	Kristen Kluska—	+173.4%	$33 → $39	Maintained	Overweight
Sep 17, 2026	Citigroup	Yigal Nochomovitz—	+117.3%	$28 → $31	Maintained	Buy
Sep 4, 2026	Goldman Sachs	Salveen Richter—	+33.2%	$28 → $19	Maintained	Neutral
Sep 4, 2026	Barclays	Eliana Merle—	+124.3%	$43 → $32	Maintained	Overweight
Sep 3, 2026	JP Morgan	Anupam Rama—	+152.3%	$80 → $36	Downgrade	Overweight→Neutral
Sep 3, 2026	Jefferies	Maury Raycroft—	+96.3%	$77 → $28	Maintained	Buy
Sep 3, 2026	William Blair	Sami Corwin—	—	—	Downgrade	Outperform→Market Perform
Sep 3, 2026	Citigroup	Yigal Nochomovitz—	+96.3%	$58 → $28	Maintained	Buy
Sep 3, 2026	TD Cowen	Yaron Werber—	+26.2%	$49 → $18	Maintained	Buy
Sep 3, 2026	Wells Fargo	Benjamin Burnett—	+26.2%	$50 → $18	Maintained	Overweight
Sep 3, 2026	Canaccord Genuity	Whitney Ijem—	+159.3%	$83 → $37	Maintained	Buy
Sep 3, 2026	Wedbush	Laura Chico—	+61.2%	$30 → $23	Maintained	Neutral
Sep 3, 2026	Evercore ISI Group	Liisa Bayko—	+12.2%	$34 → $16	Downgrade	Outperform→In-Line
Sep 3, 2026	Baird	Joel Beatty—	+12.2%	$40 → $16	Downgrade	Outperform→Neutral
Sep 3, 2026	HC Wainwright & Co.	Raghuram Selvaraju—	+75.2%	$50 → $25	Maintained	Buy
Sep 3, 2026	Cantor Fitzgerald	Kristen Kluska—	+131.3%	$103 → $33	Maintained	Overweight
Aug 28, 2026	Wells Fargo	Michael Turrin—	+250.5%	$46 → $50	Maintained	Overweight
Aug 25, 2026	JP Morgan	Anupam Rama—	+460.8%	$75 → $80	Maintained	Overweight
Aug 21, 2026	Morgan Stanley	Jeffrey Hung—	+418.7%	$67 → $74	Maintained	Overweight
Aug 20, 2026	Canaccord Genuity	Whitney Ijem—	+481.8%	$81 → $83	Maintained	Buy